Novartis Pharmaceuticals Corporation
Registered Principal Details
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Ludwig Hatson
Director, Public Affairs Operations
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Ludwig Hatson
Director, Public Affairs Operations
Contact
KH
Kathy-Jo Hayden
One Health Plaza
East Hanover, NJ 07936-1080
(862) 778-2585
(973) 781-6671
kathy-jo.hayden@novartis.com
www.novartis.com
One Health Plaza
East Hanover, NJ 07936-1080
(862) 778-2585
(973) 781-6671
kathy-jo.hayden@novartis.com
www.novartis.com
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 56
Relating to: advertising for prescription drugs.
Bill Text and History
3/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: advertising for prescription drugs.
Bill Text and History
Against
Notification Date3/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health and Family Services: Departmentwide and Management and Technology
Health and Family Services: Departmentwide and Management and Technology
Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to Prescription Drugs
Development, drafting or introduction of a proposal relating to Prescription Drugs
Action Intended To Affect
Legislative Matter
Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to Prescription Drugs
Development, drafting or introduction of a proposal relating to Prescription Drugs
Action Intended To Affect
Legislative Matter
Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceutical companies
Pharmaceutical companies
Action Intended To Affect
Legislative Matter
Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Prescription Drugs.
Prescription Drugs.
Action Intended To Affect
Legislative Matter
Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Prior authorization of prescription drugs
Prior authorization of prescription drugs
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
3/30/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
3/30/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2009 January - June $16,450.00 |
2009 July - December $0.00 |
2010 January - June $0.00 |
2010 July - December $0.00 |
Total $16,450.00 |
Total Hours Communicating | 2009 January - June 1.50 |
2009 July - December 0.00 |
2010 January - June 0.00 |
2010 July - December 0.00 |
Total 1.50 |
Total Hours Other | 2009 January - June 30.75 |
2009 July - December 10.50 |
2010 January - June 0.00 |
2010 July - December 0.00 |
Total 41.25 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: advertising for prescription drugs.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 50% |
2009 July - December |
2010 January - June |
2010 July - December |
Total 37% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 50% |
2009 July - December |
2010 January - June |
2010 July - December |
Total 38% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December 50% |
2010 January - June |
2010 July - December |
Total 12% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication